×
0 0 0 0 0.0441176470588236 -0.0514705882352942 -0.0891176470588237 -0.176470588235294
Stockreport

Apricus mulls options; to sell U.S. rights to Vitaros [Reuters (UK)]

APRICUS BIOSCIENCES (APRI)  More Company Research Source: Reuters
Last apricus biosciences earnings: 11/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: apricusbio.com
PDF Apricus mulls options; to sell U.S. rights to Vitaros | Reuters Reuters Staff 2 Min Read (Reuters) - Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug Administration asked it to make a new formula for the product. Shares of the company fell 24 percent to 32 cents in premarket trading, valuing the company at $7.5 million. Up to Friday’s close, Apricus has lost about $65 million in market value since the FDA declined to approve Vitaros in February. Apricus said it did not have the money to develop a new version and fund two new late-stage studies to meet FDA requirements. The FDA has rejected Vitaros twice in 10 years. “We have initiated discussions with interested parties for the U.S. Vitaros rights to enable its continued development and potential approval,” Chief Executive Officer Richard Pascoe said in statement. “The cost and timeline associated wit [Read more]

IMPACT SNAPSHOT EVENT TIME: APRI
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
APRI alerts
from News Quantified
Opt-in for
APRI alerts

from News Quantified
Opt-in for
APRI alerts

from News Quantified